Filing Details
- Accession Number:
- 0001144204-14-071685
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-01 19:50:27
- Reporting Period:
- 2014-11-25
- Filing Date:
- 2014-12-01
- Accepted Time:
- 2014-12-01 19:50:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1597131 | Glori Energy Inc. | GLRI | Crude Petroleum & Natural Gas (1311) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1605596 | A Matthew Gibbs | C/O Oxford Bioscience Partners 535 Boylston Street, Suite 402 Boston MA 02116 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-11-25 | 19,560 | $4.38 | 4,162,488 | No | 4 | S | Indirect | Footnotes |
Common Stock | Disposition | 2014-11-25 | 440 | $4.38 | 4,162,048 | No | 4 | S | Indirect | Footnotes |
Common Stock | Disposition | 2014-11-26 | 19,560 | $4.32 | 4,142,488 | No | 4 | S | Indirect | Footnotes |
Common Stock | Disposition | 2014-11-26 | 440 | $4.32 | 4,142,048 | No | 4 | S | Indirect | Footnotes |
Common Stock | Disposition | 2014-11-28 | 1,500 | $4.22 | 4,140,548 | No | 4 | S | Indirect | Footnotes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | Footnotes |
No | 4 | S | Indirect | Footnotes |
No | 4 | S | Indirect | Footnotes |
No | 4 | S | Indirect | Footnotes |
No | 4 | S | Indirect | Footnotes |
Footnotes
- OBP Management V L.P. is the general partner of Oxford Bioscience Partners V L.P. ("Oxford") and mRNA Fund V L.P. ("mRNA"). After the above reported transactions, Oxford owns 4,049,256 of the referenced shares and mRNA owns 91,292 of the referenced shares. Matthew Gibbs is a general partner of OBP Management V L.P. All such entities, Mr. Gibbs disclaims beneficial ownership of such shares except to the extent of their pecuniary interests in such shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- These sales were of shares owned by Oxford.
- These sales were of shares owned by mRNA.